Presentation is loading. Please wait.

Presentation is loading. Please wait.

Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed.

Published byEdith van de Velde Modified over 5 years ago

Similar presentations

Presentation on theme: "Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed."— Presentation transcript:

1 Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed less than 5 follicles  D. Aslan, I. Aruh, F. Karaarslan, T. Pinar, R. Keles, N. Demir  Fertility and Sterility  Volume 82, (September 2004) DOI: /j.fertnstert Copyright © Terms and Conditions

2 Fertility and Sterility 2004 82, DOI: (10.1016/j.fertnstert.2004.07.553)
Copyright © Terms and Conditions

3 Fertility and Sterility 2004 82, DOI: (10.1016/j.fertnstert.2004.07.553)
Copyright © Terms and Conditions

Download ppt "Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed."

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Age at menarche: a predictor of diminished ovarian function?

Age at menarche: a predictor of diminished ovarian function?
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.

The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
James P Toner, M.D., Ph.D.  Fertility and Sterility 

James P Toner, M.D., Ph.D.  Fertility and Sterility 
Patient-tailored ovarian stimulation for in vitro fertilization

Patient-tailored ovarian stimulation for in vitro fertilization
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response  Fatih Durmusoglu, M.D., Koray Elter,

Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response  Fatih Durmusoglu, M.D., Koray Elter,
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.

Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
D.H. Williams, S.A. Land, M. Han, P.D. Sutton, R.E. Brannigan 

D.H. Williams, S.A. Land, M. Han, P.D. Sutton, R.E. Brannigan 
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted.

Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted.
Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,

Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,

Similar presentations

Ads by Google